Resultados de la búsqueda 471-480 de 3471 para anti-TNF drugs
Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer ... The purpose of this study is to evaluate ...
Accessed March 23, 2023. Cummings J, et al. Alzheimer's disease drug development pipeline: 2022. Alzheimer's and Dementia. 2022; doi:10.1002/trc2.12295. Burns S ...
Drugs used in chemotherapy, such as cytarabine, idarubicin, and daunorubicin, work in different ways to stop the growth of cancer cells, either by killing ...
... treatment, post-treatment and (when available) post-mortem soft tissue sarcoma (STS) tissue and tissue data with an emphasis on STSs occurring in younger ...
The purpose of this study is to assess how well multiparametric magnetic resonance imaging (MRI) works in evaluating cancer stage and helping treatment ...
AskMayoExpert. Obesity (adult). Mayo Clinic; 2018. Pilitsi E, et al. Pharmacotherapy of obesity: Available medications and drugs under investigation. Metabolism ...
Drugs that kill "zombie" cells may benefit some older women, but not all ... Hormone therapy: Four things a Mayo Clinic women's health specialist wants ...
Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy. Adding ...
Stereotactic radiosurgery is a specialized radiation therapy that delivers a single, high dose of radiation directly to the tumor and may cause less damage to ...
... Therapy in Adults with Relapsed/ Refractory Large B Cell Lymphoma ... The purpose of this study is to evaluate the safety, tolerability, and preliminary anti ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?